255 related articles for article (PubMed ID: 30977021)
21. Multilocular Cystic Renal Cell Carcinoma: Pathological T Staging Makes No Difference to Favorable Outcomes and Should be Reclassified.
Bhatt JR; Jewett MA; Richard PO; Kawaguchi S; Timilshina N; Evans A; Alibhai S; Finelli A
J Urol; 2016 Nov; 196(5):1350-1355. PubMed ID: 27341751
[TBL] [Abstract][Full Text] [Related]
22. Histologic subtype needs to be considered after partial nephrectomy in patients with pathologic T1a renal cell carcinoma: papillary vs. clear cell renal cell carcinoma.
Yoo S; You D; Jeong IG; Song C; Hong B; Hong JH; Ahn H; Kim CS
J Cancer Res Clin Oncol; 2017 Sep; 143(9):1845-1851. PubMed ID: 28451753
[TBL] [Abstract][Full Text] [Related]
23. Laparoscopic evaluation of indeterminate renal cysts: long-term follow-up.
Limb J; Santiago L; Kaswick J; Bellman GC
J Endourol; 2002 Mar; 16(2):79-82. PubMed ID: 11962559
[TBL] [Abstract][Full Text] [Related]
24. Nephron-sparing surgery for renal cell carcinoma: clinicopathologic features predictive of patient outcome.
Krejci KG; Blute ML; Cheville JC; Sebo TJ; Lohse CM; Zincke H
Urology; 2003 Oct; 62(4):641-6. PubMed ID: 14550434
[TBL] [Abstract][Full Text] [Related]
25. Management, pathology and outcomes of Bosniak category IIF and III cystic renal lesions.
Weibl P; Hora M; Kollarik B; Shariat SF; Klatte T
World J Urol; 2015 Mar; 33(3):295-300. PubMed ID: 24744224
[TBL] [Abstract][Full Text] [Related]
26. Outcomes following partial nephrectomy by tumor size.
Crispen PL; Boorjian SA; Lohse CM; Sebo TS; Cheville JC; Blute ML; Leibovich BC
J Urol; 2008 Nov; 180(5):1912-7. PubMed ID: 18801543
[TBL] [Abstract][Full Text] [Related]
27. Long-term oncologic outcomes of hand-assisted retroperitoneoscopic radical nephrectomy to treat clinically localized renal cell carcinoma.
Hung SF; Wang SM; Chung SD; Lai MK; Huang KH; Pu YS; Yu HJ; Huang CY
J Formos Med Assoc; 2012 Jan; 111(1):41-5. PubMed ID: 22333012
[TBL] [Abstract][Full Text] [Related]
28. Bosniak Classification for Complex Renal Cysts Reevaluated: A Systematic Review.
Schoots IG; Zaccai K; Hunink MG; Verhagen PCMS
J Urol; 2017 Jul; 198(1):12-21. PubMed ID: 28286071
[TBL] [Abstract][Full Text] [Related]
29. Perioperative morbidity, oncological outcomes and predictors of pT3a upstaging for patients undergoing partial nephrectomy for cT1 tumors.
Mouracade P; Kara O; Dagenais J; Maurice MJ; Nelson RJ; Malkoc E; Kaouk JH
World J Urol; 2017 Sep; 35(9):1425-1433. PubMed ID: 28197727
[TBL] [Abstract][Full Text] [Related]
30. The operative safety and oncological outcomes of laparoscopic nephrectomy for T3 renal cell cancer.
Stewart GD; Ang WJ; Laird A; Tolley DA; Riddick AC; McNeill SA
BJU Int; 2012 Sep; 110(6):884-90. PubMed ID: 22289017
[TBL] [Abstract][Full Text] [Related]
31. Architectural Patterns are a Relevant Morphologic Grading System for Clear Cell Renal Cell Carcinoma Prognosis Assessment: Comparisons With WHO/ISUP Grade and Integrated Staging Systems.
Verine J; Colin D; Nheb M; Prapotnich D; Ploussard G; Cathelineau X; Desgrandchamps F; Mongiat-Artus P; Feugeas JP
Am J Surg Pathol; 2018 Apr; 42(4):423-441. PubMed ID: 29356723
[TBL] [Abstract][Full Text] [Related]
32. Cystic Appearance on Imaging Methods (Bosniak III-IV) in Histologically Confirmed Papillary Renal Cell Carcinoma is Mainly Characteristic of Papillary Renal Cell Carcinoma Type 1 and Might Predict a Relatively Indolent Behavior of Papillary Renal Cell Carcinoma.
Procházková K; Mírka H; Trávníček I; Pitra T; Kolár J; Roušarová M; Hošek P; Bajcurová K; Ferda J; Staehler M; Brookman May SD; Hes O; Hora M
Urol Int; 2018; 101(4):409-416. PubMed ID: 30199877
[TBL] [Abstract][Full Text] [Related]
33. Long-Term Outcomes of Patients With Low Grade Cystic Renal Epithelial Neoplasms.
Westerman ME; Cheville JC; Lohse CM; Sharma V; Boorjian SA; Leibovich BC; Thompson RH
Urology; 2019 Nov; 133():145-150. PubMed ID: 31356826
[TBL] [Abstract][Full Text] [Related]
34. [Diagnosis and laparoscopic treatment of renal cysts of Bosniak type III and IV].
Kostiukov SI; Medvedev VL; Kogan MI
Urologiia; 2008; (3):21-4. PubMed ID: 18669342
[TBL] [Abstract][Full Text] [Related]
35. Do Clear Cell Papillary Renal Cell Carcinomas Have Malignant Potential?
Diolombi ML; Cheng L; Argani P; Epstein JI
Am J Surg Pathol; 2015 Dec; 39(12):1621-34. PubMed ID: 26426379
[TBL] [Abstract][Full Text] [Related]
36. Oncological outcomes of patients with incidental pathological T3a stage small renal cell carcinoma after partial nephrectomy.
Lee C; You D; Yoo S; Song C; Hong B; Hong JH; Ahn H; Kim CS
J Cancer Res Clin Oncol; 2016 Jul; 142(7):1651-7. PubMed ID: 27193144
[TBL] [Abstract][Full Text] [Related]
37. Prognostic features of pathologic stage T1 renal cell carcinoma after radical nephrectomy.
Lau WK; Cheville JC; Blute ML; Weaver AL; Zincke H
Urology; 2002 Apr; 59(4):532-7. PubMed ID: 11927308
[TBL] [Abstract][Full Text] [Related]
38. [Risk factors for recurrence in pT3aN0M0 renal cell carcinoma according to 2009 TNM classification].
Utsunomiya N; Kono Y; Matsumoto K; Sumiyoshi T; Masuda N; Shiraishi Y; Negoro H; Tsunemori H; Sugino Y; Okubo K; Okada T; Segawa T; Muguruma K; Kawakita M
Hinyokika Kiyo; 2014 Jan; 60(1):1-5. PubMed ID: 24594765
[TBL] [Abstract][Full Text] [Related]
39. Oncological outcomes after partial vs radical nephrectomy in renal cell carcinomas of ≤7 cm with presumed renal sinus fat invasion on preoperative imaging.
Koo KC; Kim JC; Cho KS; Choi YD; Hong SJ; Yang SC; Ham WS
BJU Int; 2016 Jan; 117(1):87-93. PubMed ID: 25099267
[TBL] [Abstract][Full Text] [Related]
40. The key role of time in predicting progression-free survival in patients with renal cell carcinoma treated with partial or radical nephrectomy: conditional survival analysis.
Abdollah F; Suardi N; Capitanio U; Matloob R; Fossati N; Castiglione F; Di Trapani E; Di Trapani D; Russo A; Carenzi C; Montorsi F; Rigatti P; Bertini R
Urol Oncol; 2014 Jan; 32(1):43.e9-16. PubMed ID: 23911684
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
